print_label | resize_label


По общим вопросам деятельности компании обращайтесь в офис компании «АстраЗенека Россия» по адресу:

Офис в Москве:
125284 Москва, ул. Беговая д. 3, строение 1
Бизнес-центр NordStar Tower
Телефон +7 (495) 799-56-99 
Факс +7 (495) 799-56-98

249020, Калужская область, Боровский район,
деревня Добрино, 1-ый Восточный проезд, владение 8
Телефон +7 (48438) 2-61-00
Факс +7 (48438) 2-61-09

Medical Information Service
If you are interested in medical and scientific information about the preparations of the company, you can send a request for its receipt by e-mail or by phone 8 (495) 799-56-99 .

For questions related to health status or recommendations related to the prescription of AstraZeneca medicines, you should consult your doctor

Safety of medicines
If you become aware of a side effect when using the drug AstraZeneca, please report this information to the medical department of the company.

You can do this by e-mail to or by phone 8 (495) 799-56-99 , ext. 2580

Quality / authenticity of medicinal products
If you want to report a complaint to a drug company AstraZeneca, please contact , or call 8 (495) 799-56-99 .

Commercial activities
For business and partnership with AstraZeneca, please contact , or call 8 (495) 799-56-99 .

Work in the Company
If you are interested in working in our company, send your CV to: , or by phone at +7 (495) 799-56-99 .

If you are interested in working in the industry, send your CV to:

Work with the media
For media inquiries, please contact: A list of useful links Addresses of company offices around the world

We will try to consider your message as soon as possible. Thank you for your interest in our company.

Please note that by sending an application to the company, you automatically agree to the processing of personal data by AstraZeneca.

Privacy Information: AstraZeneca takes care of the privacy of the messages sent. Your email address will be used only to answer the question.

In case of any additional questions or comments regarding the activities of the company, use the following form: